Skip to main content
Clinical Trials/NL-OMON55672
NL-OMON55672RecruitingNot Applicable

A prospective study to evaluate long-term clinical outcomes of the GTS cementless femoral stem - H36 GTS international

Zimmer Biomet0 sites23 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
23

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1. Male and non-pregnant females : >= 18 years and <= 70 years
  • 2. Patients requiring primary THR, suitable for the use of the GTS stem.
  • 3. The patient is diagnosed with osteoarthritis (OA) or avascular necrosis.
  • 4. The individual is physically and mentally willing and able to comply with
  • postoperative functional evaluation and able to participate in an appropriate
  • rehabilitation schedule.
  • 5. ASA classification score I-III.
  • 6. Patients who signed the Ethics Committee approved specific Informed Consent
  • Form prior to surgery.
  • 7. Surgical technique is planned to be Anterior Supine Intramuscular (ASI), or
  • patient has already received a GTS hip on the contralateral side.

Exclusion Criteria

  • 1. Patients who had a THA on contralateral side more than 6 months ago and the
  • rehabilitation period outcome is considered unsatisfactory or not good.
  • (Patients with contra-lateral THA >6 months ago with good outcome (Harris Hip
  • Score >85) can be included in the study).
  • 2. Patients who had a THA on contralateral side less than 6 months ago.
  • 3. Patients with a major surgical procedure during the 12 weeks before the
  • study-related

Investigators

Similar Trials